Odyssean »

Crinetics Pharmaceuticals In shares owned by Odyssean

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.2M 85k 37.42

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Crinetics Pharmaceuticals In

FMR
BlackRock
Farallon Capital Management
Wellington Management Company
Driehaus Capital Management
T. Rowe Price Associates
Vanguard Portfolio Management
Vanguard Capital Management
Jupiter Topco
Henderson Group
EcoR1 Capital
Bellevue Group
Geode Capital Management
State Street Corporation
Baker Bros. Advisors

View all funds holding Crinetics Pharmaceuticals In